Personalising Health the Nordic Way
Chris Moore — Co-founder & CEO of the Nordic Group
”Genetics loads the gun but the environment pulls the trigger”
Chris Moore (@nordiclaboratories) is a health entrepreneur and CEO of Nordic Group.
Chris’ purpose in life and business is to change healthcare and empower populations to take responsibility for their own health. He has dedicated his career to growing the field of functional medicine. Chris has experience in laboratory analysis, nutritional supplements, and medical clinic management.
Nordic Group is composed of several subsidiaries across Europe including: Nordic Laboratories, 5 Nordic Clinics, DNAlife, Nordic Health.
They constantly invest in new technologies. Recent partnerships include:
Resistomap- antibiotic resistance measuring
Thermocheck – infrared measurement of inflammation in breast tissue
DSruptive - injectable subdermal implants to relay real-time health parameters to smartphones.
Chris Moore explores how healthcare is shifting towards individual ownership and personalized approaches, moving beyond
The most important equation in medicine is N equals one. The future of healthcare is personalized and individual, and we must steer ownership of healthcare back to the user. Healthcare is personal; it is the future.
Summary
- Health ownership belongs to the individual rather than the state or doctors, emphasizing the "N equals one" principle where individual outcomes are the primary measure of medical success. - Personalized medicine moves away from a "one-size-fits-all" approach by analyzing genomic data and lifestyle factors to predict disease risk and identify the most effective health interventions. - Genetic testing offers a look at a person’s biological infrastructure, helping to identify unique risks and performance factors that can be managed through lifestyle and environment choices. - Research into fasting-mimicking diets indicates that three to five days of fasting significantly boosts stem cell production while reducing systemic inflammation and cholesterol levels. - Advancing health technology includes non-invasive breast health monitoring via infrared cameras and the development of implants designed to measure real-time bodily functions.
Article
Personalising Health The Nordic Way
At Biohacker Summit 2020 Helsinki, Chris Moore Made The Case That Healthcare Belonged First To The Individual
In a year when much of Europe had fallen silent, the Biohacker Summit 2020 in Helsinki felt, by Chris Moore’s own admission, almost improbable. Speaking on 16 October at the gathering in Finland’s capital, Moore, CEO of Nordic Group, opened with a note of gratitude and a challenge. If this was one of the few live health events still taking place across Europe, then it was also an opportunity to ask a question that cut through the noise of modern medicine.
Who owned your health?
Not your mother, not your doctor, not the state, he argued, but you.
That proposition sat at the heart of Moore’s presentation, Personalising Health the Nordic Way, a brisk but ambitious argument for a future in which healthcare was no longer something administered from above, but something understood, monitored and acted upon by the individual. In his telling, personalized medicine was not a luxury for the affluent or the obsessive. It was the necessary correction to a system too long built on averages, abstractions and one-size-fits-all care.
The Radical Simplicity Of N Equals One
Moore reduced the philosophy to a single equation: N equals one.
It was, he said, the most important equation in medicine. A clinical study might show a treatment working for 99% of participants, but if you were the 1% left untouched or harmed, the statistic offered little comfort. Population-level success, in other words, did not erase individual reality.
That was the moral and scientific pivot of his talk. Personalized medicine, as Moore framed it, was not merely about novel gadgets or fashionable diagnostics. It was about refusing to let broad outcomes obscure the singular body, the singular patient, the singular life.
“ We are all unique. Our health is determined by our inherent differences combined with our lifestyles and environment,” he said.
That line, and others Moore cited, came not from an insurgent startup manifesto but from the NHS itself, a detail he used to sharpen his point. The future of medicine, he suggested, had already been named. The challenge was not whether personalized care would arrive, but how quickly institutions would adapt to it.
Genes As Infrastructure, Environment As Trigger
Moore’s language carried the cadence of a man trying to translate systems biology into public urgency. Genetics, he argued, offered the underlying infrastructure of the self.
“Your genes are your infrastructure. We need to know more about how we ourselves are built. It doesn't matter how your neighbor is built; how are you built?”
The phrase echoed the idea at the center of his biography and business philosophy: genetics loads the gun, but the environment pulls the trigger. It is a line often used in the field of functional medicine, but Moore returned it to first principles. Genes were not destiny. They were predisposition, architecture, pattern. Lifestyle, nutrition, stress, exposure and habit shaped whether those vulnerabilities hardened into disease or became manageable risk.
For Nordic Group, that meant building services around genomic analysis and phenotypic testing, from digestion and allergies to methylation and broader metabolic function. The goal was not simply to accumulate data, but to identify patterns before illness fully declared itself.
“By combining and analyzing information about our genome with clinical and diagnostic information, patterns can be identified that help us determine our individual risk of developing disease and detect illness earlier.”
A Functional Medicine Ambition With Nordic Scale
Moore spoke not just as a theorist but as a businessman with a network to promote. Founded in 1997, Nordic Group had grown into a collection of subsidiaries across Europe, including Nordic Laboratories, Nordic Clinics, DNAlife and Nordic Health. The mission, he said plainly, was “to change healthcare”.
That sounded grand, he acknowledged, but he defended the ambition. Part of the strategy involved expanding a chain of functional medicine clinics across major European capitals, both to deliver care and to exert pressure on politicians and the medical establishment. In Moore’s vision, these clinics would serve as practical arguments for a different model of health, one in which prevention, personalization and patient engagement were not side concerns but the main event.
He also pointed to the company’s laboratory near the University of Helsinki as a sign of Finland’s technological strength and of Nordic Group’s investment in diagnostic infrastructure. It was a fitting note for a summit that has long positioned Helsinki as a frontier city for health optimization.
The Mouth, The Mind And The Measured Self
Among the products Moore highlighted were the company’s DNA Smile and DNA Mind tests, each designed to push genetic insight into less conventional territory.
DNA Smile focused on oral health, a domain often neglected until pain arrives but increasingly recognized as deeply connected to systemic function. The oral biome, Moore argued, mattered far beyond the mouth itself.
DNA Mind turned toward cognition and behavior, seeking to illuminate how genetic variation might shape mental tendencies and vulnerabilities.
“When we understand how genes impact the way we think and behave, we can mitigate some of the challenges we may face.”
It was a striking formulation, part promise and part provocation. In an era increasingly saturated with mental health language, Moore’s pitch suggested that self-knowledge could become molecular as well as psychological. The implication was both empowering and disquieting: that the self might be rendered more legible, but also more measurable, than ever before.
Fasting, Autophagy And The Search For Regeneration
Moore then turned to one of the summit’s recurring themes: autophagy, fasting and cellular renewal. Citing the work of Dr Valter Longo at the University of Southern California, he described fasting-mimicking diets as a compelling area of research with implications for longevity, inflammation and stem cell production.
According to the evidence he referenced, three days of fasting marked a physiological threshold. By the third day, stem cell production increased sharply; by days four and five, the effect deepened further. Alongside this, he said, fasting was associated with reductions in inflammation and cholesterol.
In the language of biohacking, such interventions are often framed as tools for performance. Moore’s framing pushed further toward medicine. If diet could influence regeneration, if planned nutritional stress could alter disease risk and recovery, then food itself became part of the diagnostic and therapeutic continuum.
Technology At The Edge Of Prevention
The most futuristic portion of Moore’s talk came in his survey of emerging technologies. Here, Nordic Group’s interests stretched from antibiotic resistance to breast health monitoring and implantable sensors.
On antibiotic resistance, Moore struck his starkest note. Covid-19, he suggested, was grave but not the largest threat on the horizon. Drug-resistant infections, he warned, could become a catastrophe of far greater scale, with projections of 15 million deaths annually by 2050.
Another partnership, Thermocheck, aimed to offer women earlier and less invasive breast health monitoring through infrared imaging. The appeal was obvious: non-painful, preventative and designed to identify inflammatory signals before more serious disease emerged.
Then there was DSruptive, focused on injectable subdermal implants capable of transmitting real-time physiological data to smartphones. It was perhaps the purest expression of the worldview Moore had spent his talk constructing: a future in which the body would no longer wait passively to be examined, but would continuously report, signal and translate itself.
The Politics Of Personal Responsibility
What made Moore’s presentation notable was not simply its catalogue of tests, clinics and devices, but its underlying politics. He was asking for a cultural transfer of responsibility, away from paternal systems and toward the informed individual.
That message carries both appeal and complication. It speaks to autonomy, prevention and self-knowledge. It also raises enduring questions about access, inequality and the burden placed on people already navigating fragmented healthcare systems. Personalized medicine can empower, but it can also risk becoming yet another domain where those with resources move first and those without are left with generalized care.
Still, at Biohacker Summit 2020 Helsinki, Moore’s argument landed with clarity. He did not present healthcare as something to be passively received, but as something to be actively owned.
“Our mission is to change healthcare. Together we can do it and we must strive towards it.”
In Helsinki, that mission was framed in the idiom of the Nordic health tech ecosystem: genetic literacy, functional medicine, fasting science, infrared diagnostics and wearable or implantable monitoring. But beneath the innovation was a simpler claim, almost stubborn in its simplicity. Health, Moore insisted, was personal. The future of medicine would have to catch up with that fact.
Part of Biohacker Summit 2020 Helsinki